Replies to post #5978 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

You summed it up nicely Danny D

Danny D -

Folks don't realize this stock has the potential to explode overnight. Algernon and Cannabix are definitely targeting two different industries. The key difference is one of those industries is already well established and lucrative.. the other is brand new. I believe you said it best before... multiple shots on goal. The medical breathalyzer is of no concern to Algernon right now. 100% agree. They have bigger fish to fry right now and that's striking a Pharma deal.

Danny D said it best. ***Algernon stock could explode overnight*** Algernon remains waaay under the radar in terms of free NASH|CKD|IBD media coverage. NASH is the biggest looming epidemic on the planet. You'd have to be living on the Far Side of the Moon to not believe AGN/BTHCF will light up like a Supernova once positive data is reported for IBD in the next 11 months (Q3 2020). Followed up by two more positive data reports for Nash and CKD only months thereafter (Q1 2021). The anticipation of a positive report for one or all could nurture a global stock feeding frenzy. Danny D also makes a great point about transparency @ Algernon. Management has provided common shareholders a wealth of solid information to chew on leading up to clinical trials. The path to profits does not require AGN/BTHCF getting caught up in the weeds (pot stock stories). We must continue mowing down base-le$$ rhetoric whenever it pops up. The grass is greener on the other side of the Public Offering.

Corporate Presentation: Executive Summary - Page 32

Executive team with diverse and deep experience in drug development and financing

Chris Moreau, Chief Executive Officer

Dr. Mark Williams, Chief Science Officer



GL2ALL

DYODD

/////AM GEUSE >`>`>`

Outro:

B E T E L G E U S E